Search results

Back

COMMON QUESTIONS

90% of our funding comes from individual donors. Learn how you can support MSF’s lifesaving care with a gift.

DONATE Menu
Scroll down for content

News & stories

Get the latest news, stories, videos, and more from our medical humanitarian projects around the world.

Project Coordinator Belen Ramirez and a 17-year-old boy form Bangladesh look at a helicopter flying overhead at the End of the Wall camp in Arizona.

48 hours at the US-Mexico border

story Sep 19, 2024

News Sep 13, 2024

Sudan: After famine declaration, catastrophic malnutrition in Zamzam camp is only getting worse

A child eats ready-to-use therapeutic food to treat malnutrition in Sudan.

story Sep 20, 2024

The long road to recovery for Gaza’s war-wounded children

A boy on crutches walks in the hallway of MSF Amman hospital.

story May 15, 2024

MSF statement and position paper on antimicrobial resistance for UN High-Level Meeting

MSF bio lab at MSF’s Aden hospital

story Sep 18, 2024

Snakebite: Seven bites of inequity

Arop Magut’s foot

Speaking out about the emergencies our staff and patients witness is part of who we are. Explore our history and principles.

News & stories

5 results

News | Aug 22, 2024

WHO recommends MSF-led endTB clinical trial treatments

Wider use of shorter and effective treatment regimens studied through endTB will help improve care for people with drug-resistant TB worldwide.

Read More
Dr. Muneeba Shaikh, a medical officer sees the results of X-ray of Rehana-28 year old, drug-resistant tuberculosis patient and participant of the endTB-Q trial at endTB clinical trial clinic in Kotri, Pakistan on Monday 29 April 2024.

News | Jul 17, 2024

MSF welcomes Indian rejection of J&J patent application for pediatric TB drug

Decision will allow other drugmakers to help boost the supply of this lifesaving medicine.

Read More
An MSF staff member in India talks to a patient who was part of the EndTB clinical trial to find better treatments for tuberculosis.

News | Jun 25, 2024

Time for $5: An open letter to Danaher employees

Affordable GeneXpert tests would help people have a chance to get tested, treated, and be cured.

Read More
A letter reading "Dear Danaher employee" as part of MSF's Time for $5 campaign.

News | Apr 25, 2024

MSF publishes cost of its TB clinical trial

Transparency on clinical trial costs must become the norm to improve access to medical products worldwide.

Read More
An older patient sits with her grandson at one of MSF's active case-finding sites for tuberculosis.

News | Apr 23, 2024

As Danaher reports earnings, MSF repeats call for $5 GeneXpert tests

Medical testing shouldn't be a luxury. Danaher and Cepheid must drop the price of GeneXpert for low- and middle-income countries

Read More
Protesters holding signs in Washington, DC as part of the Time for $5 campaign.

Filters

Clear all
Country
Medical issues
Content type
Date range
For Donation Inquiries 
See donor options here. 
 
U.S. Media Inquiries 
Reach out to the press team. 
 
Non-U.S. Media Inquiries 
Contact the MSF office in your country/territory.
For Donation Inquiries 
See donor options here. 
 
U.S. Media Inquiries 
Reach out to the press team. 
 
Non-U.S. Media Inquiries 
Contact the MSF office in your country/territory.

Support our work where it’s needed most.

Your unrestricted gifts enable us to provide lifesaving medical humanitarian care on the ground and speak out about what we see.

Donate

© Médecins Sans Frontières 2024 Federal tax ID#: 13-3433452

Unrestricted donations enable MSF to carry out our programs around the world. If we cannot honor a specific request, we will reallocate your donation to where the needs are greatest.

© Médecins Sans Frontières 2024 Federal tax ID#: 13-3433452

Unrestricted donations enable MSF to carry out our programs around the world. If we cannot honor a specific request, we will reallocate your donation to where the needs are greatest.

How we use funds

Your gift helps us provide medical humanitarian aid for hundreds of thousands of people each year.

Learn more

87%

Programs

12%

Fundraising

1%

Management & General Admin

MSF